Tempus AI, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Tempus AI, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 91% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-7.4×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 52% of Healthcare companies in United States.
Cash Locked Ratio
$23For every $100 of sales, $23 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $19 tied up three years earlier.
Less money tied up than 53% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$5Sales grew 297% in 3 years; of every extra $100 of sales, $5 became extra profit.
Lower than 62% of Healthcare companies in United States.
Asset Productivity Ratio
+297% / +260%In 3 years sales changed by +297% while total assets changed by +260%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-16.3×Operating cash was negative last year, while some debt falls due within a year.
Higher than 50% of Healthcare companies in United States.
Cash Cushion Ratio
−5%Debt, after subtracting cash, equals 5% of its market value (net debt).
Lower than 74% of Healthcare companies in United States.
Tangible Assets Ratio
64%Of every $100 the company owns, $64 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 66% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 91% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Tempus AI, Inc. made a loss over the last year. Tempus AI, Inc. owes $0.81 for every $1 it owns. Tempus AI, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTempus AI, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
25.88The share price is 25.88 times Tempus AI, Inc.'s book value per share, higher than 95% of Healthcare companies in United States.
Market cap
$11.5 BThe total market value of all of Tempus AI, Inc.'s shares at today's price (share price × number of shares), larger than 91% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$445 MWhat Tempus AI, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$2.47Net worth divided by the number of shares. The share price of $63.81 is 25.9 times this, which is the P/B above.
Return on equity (ROE)
-67.4%Tempus AI, Inc. lost 67.4% of its shareholders' money over the last year, lower than 60% of Healthcare companies in United States.
Owes vs Owns
0.81×Tempus AI, Inc. owes $0.81 for every $1 it owns (high), higher than 78% of Healthcare companies in United States.
Dividend yield
NoneTempus AI, Inc. does not currently pay a dividend.
Revenue growth
+83%Revenue rose 83% in the year to Dec 2025, and grew 58% a year on average over 3 years.
Profit growth
LossTempus AI, Inc. made a loss in each of the last two years.
Profit margin
-19.3%Tempus AI, Inc. lost $19 for every $100 of revenue.
Interest cover
Not coveredTempus AI, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtTempus AI, Inc. had $572 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Tempus AI, Inc.: $11.5 B ÷ $445 M (30 Jun 2026) = 25.9.
What is Tempus AI, Inc.'s return on equity?
Tempus AI, Inc. lost 67.4% of its shareholders' money over the last year, lower than 60% of Healthcare companies in United States.
How much does Tempus AI, Inc. owe compared with what it owns?
Tempus AI, Inc. owes $0.81 for every $1 it owns (high), higher than 78% of Healthcare companies in United States.
Does Tempus AI, Inc. pay a dividend?
No. Tempus AI, Inc. does not currently pay a dividend.
Is Tempus AI, Inc.'s revenue growing?
Revenue rose 83% in the year to Dec 2025, and grew 58% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.